Companies: 10,795·Total market cap: $144.5T
Insulet Corporation

Insulet Corporation

PODDNASDAQHealthcare● Active
$153.22
+$6.81(+4.65%)
Market Cap$10.6B
P/E Ratio
52W High$354.88
52W Low$140.63
Overview

Insulet Corporation (PODD) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

podd · stock forecast · 50 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 50 Wall Street analysts in the past 3 months

SellBuy

Buy

50 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
35
Hold
12
Sell
3
Strong Sell
0
Total: 50 · Buy rate: 70.0%

12-Month Price Target

High

$280

Consensus

$227

+48.2% upside

Low

$198

Median: $220 · Last Close: $153.22

The Insulet Corporation (PODD) analyst consensus is Buy, based on ratings from 50 Wall Street analysts over the past 3 months. The average 12-month PODD price target is $227.00, representing +48.2% upside from the current price of $153.22.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $227 (48.2%)

Consensus Target

$227.00

48.2% upside

High Target

$280

82.7%

Low Target

$198

29.2%

Current Price

$153.22

as of today

Based on analyst price targets, the PODD stock price prediction for the next 12 months ranges from $198 to $280. The consensus PODD price forecast of $227.00 implies 48.2% upside from the current price of $153.22.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$149.712.29%

1-day model range: $148.2–$151.21. Peak: $151.21 (-2.29%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$124-18.9%
2028$109-28.8%
2029$100-34.5%
2030$95-37.9%
2031-40.0%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

36%7%57%
5Buy
1Neutral
8Sell
RSI (14)56.3Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · PODD · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$146.70BUY
MA 10$147.58BUY
MA 20$150.40BUY
MA 50$175.48SELL
MA 100$212.39SELL
MA 200$264.74SELL
Current $PODD · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$148.07BUY
EMA 10$148.52BUY
EMA 20$153.44SELL
EMA 50$174.84SELL
EMA 100$205.19SELL
EMA 200$236.81SELL
Current $PODD · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Citigroup2026-05-28
Maintains
NeutralNeutral
BTIG2026-05-27
Maintains
BuyBuy
RBC Capital2026-05-27
Maintains
OutperformOutperform
B of A Securities2026-05-18
Maintains
BuyBuy
Barclays2026-05-08
Maintains
UnderweightUnderweight
Oppenheimer2026-05-07
Maintains
OutperformOutperform
JP Morgan2026-05-07
Maintains
OverweightOverweight
Truist Securities2026-05-07
Maintains
BuyBuy
Evercore ISI Group2026-05-07
Maintains
OutperformOutperform
Wells Fargo2026-05-07
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on Insulet Corporation (PODD) stock. Of the recent 306 rating actions, 33 were upgrades and 36 were downgrades. 50 analysts currently cover PODD.

Analyst Recommendation Trends

Buy ratings212↑ +10
Hold ratings02↑ +2
Sell ratings01↑ +1

PODD analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 12 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$3.3B

↓ 28.9% YoY

Revenue Next Year

$4.0B

↑ 18.8% YoY

EPS This Year

$6.48

EPS Next Year

$8.12

↑ 25.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast PODD EPS of $6.48 for the current fiscal year, based on estimates from 13 analysts. The PODD revenue forecast is $3.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The PODD stock forecast is supported by two independent data sources: analyst consensus ratings from 50 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PODD price target is $227.00 (+48.2% upside), with an analyst consensus of Buy.

The PODD short-term stock prediction for tomorrow is $149.71 (-2.29%). The PODD stock price prediction for 2027 estimates an average of $124. The PODD stock prediction for 2030 projects a range of $87–$103.

Insulet Corporation trades on NASDAQ under the ticker PODD. The PODD stock outlook for 2027 is broadly positive, supported by a Buy consensus among 70% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

PODD forecast · 8 questions

According to 50 Wall Street analysts, the average 12-month PODD price target is $227.00, with a high forecast of $280.00 and a low of $198.00. The median price target is shown in the chart above when available. This implies +48.2% potential upside from the current price of $153.22.

PODD price targetWhat is PODD price targetPODD analyst price targetPODD 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.